Opaxio paclitaxel poliglumex: Phase II data

Additional data from an ongoing, open-label Phase II trial in 40 patients showed that

Read the full 145 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE